From: Clinical characteristics of immune tolerance after pediatric liver transplantation
Tolerance(n = 15) | Controls (n = 22) | p value | |
---|---|---|---|
Age of the recipient at transplant, Mon, Median (range) | 6.2 (2.8–10.3) | 14.5 (5.7–156.6) | < 0.001 |
Primary disease | |||
Biliary atresia | 14 | 11 | 0.011 |
Glycogen storage disease | 0 | 4 | 0.13 |
Wilson’s disease | 0 | 2 | 0.51 |
Unexplained hepatic cirrhosis | 1 | 5 | 0.37 |
Transplant mode | |||
LDLT | 15 | 13 | 0.005 |
DCD | 0 | 9 | |
Donor’s gender | |||
M | 2 | 10 | 0.073 |
F | 13 | 12 | |
Recipient’s gender | |||
M | 7 | 9 | 0.75 |
F | 8 | 13 | |
Blood matching | |||
Identical | 6 | 10 | 0.51 |
Compatible | 9 | 12 | 0.51 |
Incompatible | 0 | 0 | – |
Time post-LT (m) | 48.6 (23.5–79.2) | 35.3 (15.2–112.6) | 0.26 |